The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Liquid biopsy using plasma proteomic profiling to reveal predictors of immunotherapy response.
 
Arnav Mehta
No Relationships to Disclose
 
Gyulnara Kasumova
No Relationships to Disclose
 
Marijana Rucevic
No Relationships to Disclose
 
Markus Sallman-Almen
No Relationships to Disclose
 
Lina Hultin Rosenberg
No Relationships to Disclose
 
Michelle S. Kim
No Relationships to Disclose
 
David Lieb
No Relationships to Disclose
 
Xue Bai
No Relationships to Disclose
 
Dennie T. Frederick
No Relationships to Disclose
 
Ryan J. Sullivan
Honoraria - Roche/Genentech
Consulting or Advisory Role - ACI Clinical; Amgen; Array BioPharma; Biodesix; BiolineRx; Compugen; Merck; Novartis; Replimune; Syndax; Takeda; WorldCare Clinical, LLC
Research Funding - Aeglea Biotherapeutics (Inst); Amgen (Inst); Asana Biosciences (Inst); BioMed Valley Discoveries (Inst); Deciphera (Inst); Lilly (Inst); Merck (Inst); Moderna Therapeutics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Other Relationship - Boehringer Ingelheim
 
Keith Flaherty
Stock and Other Ownership Interests - Clovis Oncology; Loxo; Strata Oncology; X4 Pharma
Consulting or Advisory Role - Adaptimmune; Aeglea Biotherapeutics; Amgen; Asana Biosciences; Bristol-Myers Squibb; Genentech; Incyte; Lilly; Loxo; Merck; Novartis; Oncoceutics; Roche; Sanofi; Shattuck Labs; Tolero Pharmaceuticals
Research Funding - Novartis; Sanofi
 
Nir Hacohen
Stock and Other Ownership Interests - IFM Therapeutics; Neon Therapeutics; Neon Therapeutics (I)
Consulting or Advisory Role - IFM Therapeutics; Neon Therapeutics; Neon Therapeutics (I)
Research Funding - Pfizer/EMD Serono; Sanofi
Patents, Royalties, Other Intellectual Property - Neon Therapeutics; Neon Therapeutics (I)
 
Genevieve Marie Boland
Research Funding - Takeda